Rene Haas, CEO of chip designer Arm Holdings, predicts that AI will eventually find a cure for cancer within our lifetime by solving complex DNA modeling problems. He highlighted that current AI and human capabilities are insufficient but expect advances as AI models and computing power improve. Haas also foresees widespread use of humanoid robots within five years, enabled by AI's ability to learn and adapt to new tasks. Arm is a major player in chip design, supporting global tech giants, and Haas recently took a leadership role at SoftBank's international business, a key tech investor.
Semiconductor and memory stocks unexpectedly rose following a stronger-than-expected August jobs report showing 162,000 new payrolls versus 56,000 expected. This rally contrasts with declines in most non-AI stocks, suggesting some selling pressure in...
Marvell Technology's stock rose 6% after recent declines, driven by renewed investor interest in AI silicon linked to hyperscaler spending. The company benefits from custom silicon and data-center demand, unlike Qualcomm, which has less exposure to c...
